182 related items for PubMed ID: 7621563
1. Adrenarche does not occur in treated patients with congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.
Brunelli VL, Chiumello G, David M, Forest MG.
Clin Endocrinol (Oxf); 1995 May; 42(5):461-6. PubMed ID: 7621563
[Abstract] [Full Text] [Related]
2. 'Exaggerated adrenarche' in children presenting with premature adrenarche.
Likitmaskul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B, Silink M.
Clin Endocrinol (Oxf); 1995 Mar; 42(3):265-72. PubMed ID: 7758231
[Abstract] [Full Text] [Related]
3. Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Sellers EP, MacGillivray MH.
Endocr Res; 1995 Aug; 21(3):537-44. PubMed ID: 7588424
[Abstract] [Full Text] [Related]
4. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Öhl L, Rauh M, Schöfl C, Dörr HG.
Horm Res Paediatr; 2011 Aug; 76(6):400-10. PubMed ID: 22123283
[Abstract] [Full Text] [Related]
5. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Sólyom J, Gács G, Keszei K, Láng K, Orley J, Petheö I, Ságodi L.
Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
[Abstract] [Full Text] [Related]
6. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
Granoff AB, Chasalow FI, Blethen SL.
J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
[Abstract] [Full Text] [Related]
7. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
Morris AH, Reiter EO, Geffner ME, Lippe BM, Itami RM, Mayes DM.
J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
[Abstract] [Full Text] [Related]
8. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
Azziz R, Bradley EL, Potter HD, Boots LR.
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
[Abstract] [Full Text] [Related]
9. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
Linder B, Feuillan P, Chrousos GP.
J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
[Abstract] [Full Text] [Related]
10. Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
Benjamin F, Deutsch S, Saperstein H, Seltzer VL.
Fertil Steril; 1986 Aug; 46(2):215-21. PubMed ID: 3015693
[Abstract] [Full Text] [Related]
11. Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Rezvani I, Garibaldi LR, Digeorge AM, Artman HG.
Pediatr Res; 1983 Feb; 17(2):131-4. PubMed ID: 6219334
[Abstract] [Full Text] [Related]
12. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
Solish SB, Goldsmith MA, Voutilainen R, Miller WL.
J Clin Endocrinol Metab; 1989 Dec; 69(6):1148-52. PubMed ID: 2555382
[Abstract] [Full Text] [Related]
13. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibañez L, Bernasconi S.
J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
[Abstract] [Full Text] [Related]
14. Isolated precocious pubarche: an approach.
Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V.
J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
[Abstract] [Full Text] [Related]
15. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT, Gourmelen M, Raux-Eurin MC, Girard F.
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[Abstract] [Full Text] [Related]
16. Anthropometric and endocrine features in girls with isolated premature pubarche or non-classical congenital adrenal hyperplasia.
Accetta SG, Di Domênico K, Ritter CG, Ritter AT, Capp E, Spritzer PM.
J Pediatr Endocrinol Metab; 2004 May; 17(5):767-73. PubMed ID: 15237712
[Abstract] [Full Text] [Related]
17. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G, Camanni F, Messina M.
Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
[Abstract] [Full Text] [Related]
18. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.
Armengaud JB, Charkaluk ML, Trivin C, Tardy V, Bréart G, Brauner R, Chalumeau M.
J Clin Endocrinol Metab; 2009 Aug; 94(8):2835-40. PubMed ID: 19454583
[Abstract] [Full Text] [Related]
19. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Siegel SF, Finegold DN, Lanes R, Lee PA.
N Engl J Med; 1990 Sep 27; 323(13):849-54. PubMed ID: 2168515
[Abstract] [Full Text] [Related]
20. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Horrocks PM, London DR.
Clin Endocrinol (Oxf); 1982 Dec 27; 17(6):547-56. PubMed ID: 6299623
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
